BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20060688)

  • 1. Topical application of anti-angiogenic peptides based on pigment epithelium-derived factor can improve psoriasis.
    Abe R; Yamagishi S; Fujita Y; Hoshina D; Sasaki M; Nakamura K; Matsui T; Shimizu T; Bucala R; Shimizu H
    J Dermatol Sci; 2010 Mar; 57(3):183-91. PubMed ID: 20060688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEDF: a potential molecular therapeutic target with multiple anti-cancer activities.
    Ek ET; Dass CR; Choong PF
    Trends Mol Med; 2006 Oct; 12(10):497-502. PubMed ID: 16962374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
    Zhang T; Guan M; Xu C; Chen Y; Lu Y
    Life Sci; 2007 Sep; 81(16):1256-63. PubMed ID: 17919663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ratio of VEGF/PEDF expression in bone marrow mesenchymal stem cells regulates neovascularization.
    Fan W; Crawford R; Xiao Y
    Differentiation; 2011 Mar; 81(3):181-91. PubMed ID: 21236558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
    Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
    Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma.
    Ek ET; Dass CR; Contreras KG; Choong PF
    J Orthop Res; 2007 Dec; 25(12):1671-80. PubMed ID: 17600821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions.
    Yafai Y; Lange J; Wiedemann P; Reichenbach A; Eichler W
    Glia; 2007 Apr; 55(6):642-51. PubMed ID: 17309061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A physiological approach for treating endometriosis by recombinant pigment epithelium-derived factor (PEDF).
    Chuderland D; Hasky N; Ben-Ami I; Kaplan-Kraicer R; Grossman H; Shalgi R
    Hum Reprod; 2013 Jun; 28(6):1626-34. PubMed ID: 23466670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.
    Xu Z; Fang S; Zuo Y; Zhang Y; Cheng R; Wang Q; Yang Z; Cai W; Ma J; Yang X; Gao G
    Cancer Sci; 2011 Oct; 102(10):1789-98. PubMed ID: 21707863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pigment epithelium-derived factor (PEDF): drug developmental challenges ahead for a budding anti-angiogenic.
    Dass CR; Choong PF
    Pharmazie; 2008 Jan; 63(1):4-6. PubMed ID: 18271294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
    Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered pigment epithelium-derived factor and vascular endothelial growth factor levels in lymphangioma pathogenesis and clinical recurrence.
    Sidle DM; Maddalozzo J; Meier JD; Cornwell M; Stellmach V; Crawford SE
    Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):990-5. PubMed ID: 16301371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEDF-derived peptide inhibits corneal angiogenesis by suppressing VEGF expression.
    Matsui T; Nishino Y; Maeda S; Yamagishi S
    Microvasc Res; 2012 Jul; 84(1):105-8. PubMed ID: 22386653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth suppression of cervical carcinoma by pigment epithelium-derived factor via anti-angiogenesis.
    Yang J; Chen S; Huang X; Han J; Wang Q; Shi D; Cheng R; Gao G; Yang X
    Cancer Biol Ther; 2010 Jun; 9(12):967-74. PubMed ID: 20364117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
    J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the collagen I-binding motif in the anti-angiogenic activity of pigment epithelium-derived factor.
    Hosomichi J; Yasui N; Koide T; Soma K; Morita I
    Biochem Biophys Res Commun; 2005 Sep; 335(3):756-61. PubMed ID: 16102727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model.
    Abramson LP; Stellmach V; Doll JA; Cornwell M; Arensman RM; Crawford SE
    J Pediatr Surg; 2003 Mar; 38(3):336-42; discussion 336-42. PubMed ID: 12632345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells.
    Takenaka K; Yamagishi S; Jinnouchi Y; Nakamura K; Matsui T; Imaizumi T
    Life Sci; 2005 Nov; 77(25):3231-41. PubMed ID: 15985268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.
    Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM
    J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis--a possible target for novel therapies?
    Canavese M; Altruda F; Ruzicka T; Schauber J
    J Dermatol Sci; 2010 Jun; 58(3):171-6. PubMed ID: 20430590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.